Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1984
Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: an analysis of the RTOG head and neck registry
T W Griffin, T F Pajak, B W Gillespie, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1983
Split-course versus continuous pelvis irradiation in carcinoma of the uterine cervix: a prospective randomized clinical trial of the Radiation Therapy Oncology Group
V A Marcial, D A Amato, R D Marks, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 1989
Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: preliminary results of RTOG 83-07
M V Pilepich, J M Krall, M J John, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1996
Results of a phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer (RTOG Protocol 90-20)
C A Lawton, C N Coleman, J W Buzydlowski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 1990
Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13
J D Cox, T F Pajak, V A Marcial, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 1991
ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313
J D Cox, T F Pajak, V A Marcial, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 11, 1991
Elapsed treatment days--a critical item for radiotherapy quality control review in head and neck trials: RTOG report
T F Pajak, G E Laramore, V A Marcial, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Logistics in designing clinical trials for etanidazole (SR 2508): an RTOG experience
D J Lee, T L Phillips, C N Coleman, et al.
Cancer
|
January 15, 1987
Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study
M Al-Sarraf, T F Pajak, V A Marcial, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1991
Improved linac dose distributions for radiosurgery with elliptically shaped fields
C F Serago, A A Lewin, P V Houdek, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1984
Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: an analysis of the RTOG head and neck registry
T W Griffin, T F Pajak, B W Gillespie, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1983
Split-course versus continuous pelvis irradiation in carcinoma of the uterine cervix: a prospective randomized clinical trial of the Radiation Therapy Oncology Group
V A Marcial, D A Amato, R D Marks, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 1989
Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: preliminary results of RTOG 83-07
M V Pilepich, J M Krall, M J John, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1996
Results of a phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer (RTOG Protocol 90-20)
C A Lawton, C N Coleman, J W Buzydlowski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 1990
Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13
J D Cox, T F Pajak, V A Marcial, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 1991
ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313
J D Cox, T F Pajak, V A Marcial, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 11, 1991
Elapsed treatment days--a critical item for radiotherapy quality control review in head and neck trials: RTOG report
T F Pajak, G E Laramore, V A Marcial, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Logistics in designing clinical trials for etanidazole (SR 2508): an RTOG experience
D J Lee, T L Phillips, C N Coleman, et al.
Cancer
|
January 15, 1987
Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study
M Al-Sarraf, T F Pajak, V A Marcial, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1991
Improved linac dose distributions for radiosurgery with elliptically shaped fields
C F Serago, A A Lewin, P V Houdek, et al.
Page
of 6